Header Logo

Connection

BORIS BLECHACZ to Signal Transduction

Back to Details
This is a "connection" page, showing publications BORIS BLECHACZ has written about Signal Transduction.
BORIS BLECHACZ
Connection Strength
0.151
Signal Transduction
  1. Sorafenib inhibits signal transducer and activator of transcription-3 signaling in cholangiocarcinoma cells by activating the phosphatase shatterproof 2. Hepatology. 2009 Dec; 50(6):1861-70.
    View in: PubMed
    Score: 0.100
  2. Hepatocellular carcinoma biology. Recent Results Cancer Res. 2013; 190:1-20.
    View in: PubMed
    Score: 0.031
  3. Loss of the transforming growth factor-? effector ?2-Spectrin promotes genomic instability. Hepatology. 2017 02; 65(2):678-693.
    View in: PubMed
    Score: 0.010
  4. A Positive TGF-?/c-KIT Feedback Loop Drives Tumor Progression in Advanced Primary Liver Cancer. Neoplasia. 2016 06; 18(6):371-86.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.